mail
versión imprimible
 
 

2nd ADC Target Selection Summit

Evvnt Promotion / evvnt
-
06.12.2022 - 08.12.2022  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 09:00 - 16:00
 
Temas de la conferencia
With no room for error in the highly competitive ADC market and no going back after you have selected your target, it is vital that drug developers optimally triangulate the linker-payload, target and indication to develop an ADC that can have the biggest impact on patients.

Recent exciting developments in linker-payload technologies and clinical efficacy in low-expressed tumors have propelled this conversation to the forefront of mind.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1261856-3?pid=4832

Speakers: Jagath Reddy Junutula, President, Chief Executive Officer and Co-Founder, Aarvik Therapeutics, Yu Shen, Director, Oncology Discovery, AbbVie, and more.
 

Información e inscripción:

https://go.evvnt.com/1261856-2?pid=4832
Ms. Aarti Diwan
 
Categorías
Oncología
Idioma
Inglés
Cuota del Congreso
USD 2499.00 - USD 4697.00
Los participantes esperaban
500 - 500
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Center of ExcellenceCharité International AcademyOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienEuropean Health Forum GasteinAMREF - African Medical and Research FoundationÖsterreichisches Rotes Kreuz